Clinical Trial Update: Clinical Therapeutic Potential of Novel Microbiome LP-51 on Xerosis Individual Based on Xerosis-microbiome Index [Phase 1, Phase 2]

View source ↗

Summary

Clinical trial update on LP-51 microbiome therapy for Xerosis across Phase 1 and Phase 2 studies; the trial has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Xerosis

Drugs mentioned

• LP-51

Snippet

Sponsor: Ho-Yeon Song | Conditions: Xerosis | Phase 1, Phase 2 | Status: COMPLETED